LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

LLY

1,115.8

+0.57%↑

JNJ

241.13

+0.72%↑

ABBV

234.57

-0.1%↓

UNH

405.65

-0.9%↓

MRK

120.63

+0.84%↑

Search

Champions Oncology Inc

Chiusa

SettoreSettore sanitario

6.26 1.29

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

5.45

Massimo

6.41

Metriche Chiave

By Trading Economics

Entrata

-514K

-278K

Vendite

1.5M

17M

P/E

Media del settore

35.118

50.958

EPS

-0.02

Margine di Profitto

-1.679

Dipendenti

213

EBITDA

-508K

104K

Dividendi

By Acuity

Utili prossimi

22 lug 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

3.9M

87M

Apertura precedente

4.97

Chiusura precedente

6.26

Notizie sul Sentiment di mercato

By Acuity

100%

0%

323 / 342 Classifica in Healthcare

Champions Oncology Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Chi Siamo Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat